Medical Research

What Are Stem Cells?

Stem cells: What s missing? 11 to 14 year olds February 2010, updated Jan 2011.What are stem cells?.Use these words to fill in the gaps.Cells are the building blocks of all living things. Your body is made up of 210 different kinds of cells blood cells

What Are Stem Cells and Why Are They Important?

A stem cell is a cell whose job in the body is not yet determined. All other cells in the body stem from these type of cells (hence the name).Stem cells wait in the body until they get a signal to DIFFERENTIATE, or gradually change into the desired cell

Give Me a Few Minutes of Your Time

Give me a few minutes of your time. It may change your life.5 years ago I was introduced to a research breakthrough surrounding adult stem cells that produced a successful networking company. Being in the right place at the right time and taking decisive

Which Irbs Are Required to Review This Proposal?

KUSM-W, VCH-W, WMREF Prospective Application Ver: August 2013.Which IRBs are required to review this proposal?.KU School of Medicine-Wichita (KUSM-W) 316-293-2610.Via Christi Hospitals Wichita, Inc. (VCH-W) 316-268-5114.Wichita Medical Research & Education Foundation (WMREF) 316-686-7172

History of Clinical Research a Merging of Diverse Cultures

History of Clinical Research A Merging of Diverse Cultures.Course Overview.History of Clinical Research.2010 2011 IPPCR Enrollment Date.enrolled at the NIH: 459.enrolled at 32 remote locations 1,035.Total enrollees (as of 10/18/10) 1,494.32 Participating Off-Campus Sites

Descriptive Research Protocol

SPONSOR CONFIDENTIAL.Drug Name Protocol No. XXXXX.PROTOCOL TEMPLATE: DESCRIPTIVE STUDY.This simplified protocol template may be used for retrospective descriptive research. This includes chart reviews of existing data that have purely descriptive objectives

Survey Questions Given to Subjects

Survey Questions Given to Subjects

Survey from PI.Research investigators may use or adapt the following sample survey to obtain feedback from study participants to support quality improvement of human subject protection practices and the informed consent process. REDCap electronic data

University of Connecticut

Instructions for Completing the IRB-4.Adverse Event Report Form.Timeline for Reporting of Adverse Events.Using the Adverse Event Report Form (IRB-4), PIs are required to report to the IRB serious and related events no later than 2 working days after discovery

Recommendations for the Development of Informed Consent Documents for Cancer Clinical Trials

Recommendations for the Development of Informed Consent Documents for Cancer Clinical Trials.BY THE COMPREHENSIVE WORKING GROUP ON INFORMED CONSENT IN CANCER CLINICAL TRIALS FOR THE NATIONAL CANCER INSTITUTE.Background of the Issues.o Recommendations for Specific Federally-Required Consent Elements

Submission Requirements for New Research Applications

Submission Requirements for New Research Applications.Principal Investigator s Current Curriculum Vitae (CV).Must be signed and dated, within 1 year.Not required if current documentation is already on file with BRANY IRB.Principal Investigator s Current Professional License (if applicable)

Workshop on Practice-Based Research (PBR) and Pragmatic Studies

Workshop on Practice-Based Research (PBR) and Pragmatic Studies.Medical Education & Telemedicine Building / Learning Centers UC San Diego, La Jolla, CA.In this experiential workshop, clinicians will learn how practice-based research can be a powerful

Request for IRB Reivew

PART III - Request for IRB Review.PHARMACEUTICAL AGENTS.RADIOACTIVE SUBSTANCES Approval is Required from the Hospital Radiation Safety Committee.BIOHAZARDOUS MATERIALS - Approval is Required from the Research Safety Subcommittee.Significant 21 CFR Part 812.Non-Significant 21 CFR 812.2(b)

Report to Aapm Radiation Therapy Committee

RPC Report to the AAPM Therapy Physics Committee Page 15 of 15.REPORT TO THE AAPM THERAPY PHYSICS COMMITTEE.In lieu of a specific report addressed to the Therapy Physics Committee, the RPC is providing the text for this section from the annual non-competing

Essential Documents During the Clinical Study

ESSENTIAL DOCUMENTS DURING THE CLINICAL STUDY.*International Conference on Harmonisation: Harmonised Tripartite Guideline for Good Clinical Practice E6 (CPMP/ICH/135/95), European Commission (1996)

Creighton University

Creighton University.Institutional Biosafety Committee.Policies and Procedures for the Use of Biohazardous Materials (Recombinant or Synthetic Nucleic Acid Molecules, Infectious Biological Agents and Select Agents and Select Agent Toxins).Institutional Biosafety Committee.2500 California Plaza

NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines)

NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).SELECTED GENERAL INVESTIGATOR RESPONSIBILITIES including Reporting for.Principal Investigators at Added Clinical Sites (Gene transfer studies) (pages 27-29).Section IV-B-7-a. General Responsibilities

上一页53545556575859606162下一页
Top View